JP2012525336A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012525336A5 JP2012525336A5 JP2012507475A JP2012507475A JP2012525336A5 JP 2012525336 A5 JP2012525336 A5 JP 2012525336A5 JP 2012507475 A JP2012507475 A JP 2012507475A JP 2012507475 A JP2012507475 A JP 2012507475A JP 2012525336 A5 JP2012525336 A5 JP 2012525336A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- inden
- oxo
- dihydropyridine
- carboxamide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 44
- -1 R 13 Chemical compound 0.000 claims 15
- 150000003839 salts Chemical class 0.000 claims 15
- 239000012453 solvate Substances 0.000 claims 15
- 239000000203 mixture Substances 0.000 claims 11
- 125000003118 aryl group Chemical group 0.000 claims 9
- 125000001072 heteroaryl group Chemical group 0.000 claims 9
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 8
- 125000006584 (C3-C10) heterocycloalkyl group Chemical group 0.000 claims 7
- 125000004404 heteroalkyl group Chemical group 0.000 claims 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 7
- 102000006495 integrins Human genes 0.000 claims 6
- 108010044426 integrins Proteins 0.000 claims 6
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 5
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 claims 4
- 125000006376 (C3-C10) cycloalkyl group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 230000027455 binding Effects 0.000 claims 4
- 150000003857 carboxamides Chemical class 0.000 claims 4
- 239000003446 ligand Substances 0.000 claims 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 3
- MGTSRKSZRYSNRG-UHFFFAOYSA-N 1-(4-bromo-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(Br)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 MGTSRKSZRYSNRG-UHFFFAOYSA-N 0.000 claims 3
- WBJYXSTVRZMYHR-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-(4-phenoxyphenyl)pyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 WBJYXSTVRZMYHR-UHFFFAOYSA-N 0.000 claims 3
- DLWITLRKVVCPBW-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 DLWITLRKVVCPBW-UHFFFAOYSA-N 0.000 claims 3
- 125000004429 atom Chemical group 0.000 claims 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 238000000099 in vitro assay Methods 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229930192474 thiophene Natural products 0.000 claims 3
- WFOKKBXIFGWUGP-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-(4-phenylphenyl)pyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=CC=C1 WFOKKBXIFGWUGP-UHFFFAOYSA-N 0.000 claims 2
- BYQYNXXZYYARKU-UHFFFAOYSA-N 1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-phenylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)N3CCOCC3)CC2)C(=O)C=1C(=O)NC1=CC=CC=C1 BYQYNXXZYYARKU-UHFFFAOYSA-N 0.000 claims 2
- NOXXXWUZNCFIGU-UHFFFAOYSA-N 1-(6-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C12=CC(OC)=CC=C2CCC1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 NOXXXWUZNCFIGU-UHFFFAOYSA-N 0.000 claims 2
- 102000016359 Fibronectins Human genes 0.000 claims 2
- 108010067306 Fibronectins Proteins 0.000 claims 2
- 238000003556 assay Methods 0.000 claims 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 2
- 208000027866 inflammatory disease Diseases 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- CCKYEVWPJBLGSL-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=CC=CC=C3CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 CCKYEVWPJBLGSL-UHFFFAOYSA-N 0.000 claims 1
- FHSNQTUPSULWBN-UHFFFAOYSA-N 1-(3-methyl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C12=CC=CC=C2C(C)CC1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 FHSNQTUPSULWBN-UHFFFAOYSA-N 0.000 claims 1
- XFVUNFLEGLIUBD-UHFFFAOYSA-N 1-(4-acetamido-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(NC(=O)C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 XFVUNFLEGLIUBD-UHFFFAOYSA-N 0.000 claims 1
- GOEROXFHACADLC-UHFFFAOYSA-N 1-(4-amino-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(N)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 GOEROXFHACADLC-UHFFFAOYSA-N 0.000 claims 1
- WOJIKDNMHKTBQP-UHFFFAOYSA-N 1-(4-bromo-2,3-dihydro-1h-inden-1-yl)-n-(4-chlorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2Br)=C2CC1 WOJIKDNMHKTBQP-UHFFFAOYSA-N 0.000 claims 1
- FNFRZOUOMFBWCP-UHFFFAOYSA-N 1-(4-chloro-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(Cl)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 FNFRZOUOMFBWCP-UHFFFAOYSA-N 0.000 claims 1
- KPWKCFBQCLGQGD-UHFFFAOYSA-N 1-(4-cyano-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)C#N)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 KPWKCFBQCLGQGD-UHFFFAOYSA-N 0.000 claims 1
- KPLCFCSBJAOAAU-UHFFFAOYSA-N 1-(4-cyclopropyl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)C3CC3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 KPLCFCSBJAOAAU-UHFFFAOYSA-N 0.000 claims 1
- PQLTUTXADSMBCD-UHFFFAOYSA-N 1-(4-hydroxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-(4-phenylphenyl)pyridine-3-carboxamide Chemical compound C1CC=2C(O)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=CC=C1 PQLTUTXADSMBCD-UHFFFAOYSA-N 0.000 claims 1
- VXPGVFBGQUKIRD-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(OC(F)(F)F)C=C1 VXPGVFBGQUKIRD-UHFFFAOYSA-N 0.000 claims 1
- ZWTIJGFALYXVJT-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-phenylpyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=CC=C1 ZWTIJGFALYXVJT-UHFFFAOYSA-N 0.000 claims 1
- SNCIYGCAKRMIIC-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-n-[4-(2-methoxyphenyl)phenyl]-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=CC=C1OC SNCIYGCAKRMIIC-UHFFFAOYSA-N 0.000 claims 1
- MDKSZGHWXVNNHA-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-n-[4-(4-methoxyphenoxy)phenyl]-2-oxopyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1OC(C=C1)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2OC)=C2CC1 MDKSZGHWXVNNHA-UHFFFAOYSA-N 0.000 claims 1
- JVBDRUXNLPUACH-UHFFFAOYSA-N 1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-n-[4-(4-methoxyphenyl)phenyl]-2-oxopyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1C(C=C1)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2OC)=C2CC1 JVBDRUXNLPUACH-UHFFFAOYSA-N 0.000 claims 1
- RBHNCUWUVWCSAY-UHFFFAOYSA-N 1-(4-methyl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 RBHNCUWUVWCSAY-UHFFFAOYSA-N 0.000 claims 1
- IQQACCNUSCXUCA-UHFFFAOYSA-N 1-(4-methylsulfanyl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(SC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 IQQACCNUSCXUCA-UHFFFAOYSA-N 0.000 claims 1
- MSJRPOFHRHBTEH-UHFFFAOYSA-N 1-(4-methylsulfonyl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(S(=O)(=O)C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 MSJRPOFHRHBTEH-UHFFFAOYSA-N 0.000 claims 1
- FQGJWZPCMJLUFK-UHFFFAOYSA-N 1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-(4-phenoxyphenyl)pyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)N3CCOCC3)CC2)C(=O)C=1C(=O)NC(C=C1)=CC=C1OC1=CC=CC=C1 FQGJWZPCMJLUFK-UHFFFAOYSA-N 0.000 claims 1
- OMZUTCXYMPZTTO-UHFFFAOYSA-N 1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-[4-(trifluoromethoxy)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(OC(F)(F)F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 OMZUTCXYMPZTTO-UHFFFAOYSA-N 0.000 claims 1
- OLISEGVDHLJMND-UHFFFAOYSA-N 1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-[4-(trifluoromethyl)phenyl]pyridine-3-carboxamide Chemical compound C1=CC(C(F)(F)F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 OLISEGVDHLJMND-UHFFFAOYSA-N 0.000 claims 1
- YCIZPTKCERATII-UHFFFAOYSA-N 1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)N3CCOCC3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 YCIZPTKCERATII-UHFFFAOYSA-N 0.000 claims 1
- MYVYMEPVMOHNMF-UHFFFAOYSA-N 1-(4-nitro-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C([N+](=O)[O-])=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 MYVYMEPVMOHNMF-UHFFFAOYSA-N 0.000 claims 1
- QIUSZEHWTSLBQF-UHFFFAOYSA-N 1-(6-bromo-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C12=CC(Br)=CC=C2CCC1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 QIUSZEHWTSLBQF-UHFFFAOYSA-N 0.000 claims 1
- BGQSTCMBYRTACM-UHFFFAOYSA-N 1-(6-bromo-2,3-dihydro-1h-inden-1-yl)-n-(4-chlorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C2=CC(Br)=CC=C2CC1 BGQSTCMBYRTACM-UHFFFAOYSA-N 0.000 claims 1
- RAWJRBXOODIXOY-UHFFFAOYSA-N 1-(7,8-dihydro-6h-cyclopenta[g][1,3]benzodioxol-6-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C=4OCOC=4C=C3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 RAWJRBXOODIXOY-UHFFFAOYSA-N 0.000 claims 1
- UUBVYYFMGGHBAK-UHFFFAOYSA-N 1-(7-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1=2C(OC)=CC=CC=2CCC1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 UUBVYYFMGGHBAK-UHFFFAOYSA-N 0.000 claims 1
- CCKYEVWPJBLGSL-GOSISDBHSA-N 1-[(1r)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN([C@H]2C3=CC=CC=C3CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 CCKYEVWPJBLGSL-GOSISDBHSA-N 0.000 claims 1
- WQDDRSUCGRFFEB-ZWKOTPCHSA-N 1-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound O=C1N([C@@H]2C3=CC=CC=C3C[C@@H]2O)C=CC=C1C(=O)NC1=CC=NC=C1 WQDDRSUCGRFFEB-ZWKOTPCHSA-N 0.000 claims 1
- CCKYEVWPJBLGSL-SFHVURJKSA-N 1-[(1s)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN([C@@H]2C3=CC=CC=C3CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 CCKYEVWPJBLGSL-SFHVURJKSA-N 0.000 claims 1
- WQDDRSUCGRFFEB-MSOLQXFVSA-N 1-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound O=C1N([C@H]2C3=CC=CC=C3C[C@H]2O)C=CC=C1C(=O)NC1=CC=NC=C1 WQDDRSUCGRFFEB-MSOLQXFVSA-N 0.000 claims 1
- QRKJFFQWCLAZIT-UHFFFAOYSA-N 1-[4-(4-acetylpiperazin-1-yl)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CN(C(=O)C)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CN=CC=2)=CC=C1 QRKJFFQWCLAZIT-UHFFFAOYSA-N 0.000 claims 1
- NRVCMCNZPQSNPP-UHFFFAOYSA-N 1-[4-(4-hydroxypiperidin-1-yl)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC(O)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CN=CC=2)=CC=C1 NRVCMCNZPQSNPP-UHFFFAOYSA-N 0.000 claims 1
- ICPVZTPGZXVHTQ-UHFFFAOYSA-N 1-[4-(4-methylpiperazin-1-yl)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CN(C)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CN=CC=2)=CC=C1 ICPVZTPGZXVHTQ-UHFFFAOYSA-N 0.000 claims 1
- XCCQYAUZLYVYON-UHFFFAOYSA-N 1-[4-(cyclopropylamino)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)NC3CC3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 XCCQYAUZLYVYON-UHFFFAOYSA-N 0.000 claims 1
- MUZKIXYETQBYFS-UHFFFAOYSA-N 1-[4-(dimethylamino)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(N(C)C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 MUZKIXYETQBYFS-UHFFFAOYSA-N 0.000 claims 1
- URUJZJKZXLMCCO-UHFFFAOYSA-N 1-[4-(methylamino)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(NC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 URUJZJKZXLMCCO-UHFFFAOYSA-N 0.000 claims 1
- DOVUJQMOXPYQMQ-UHFFFAOYSA-N 1-[4-(methylcarbamoyl)-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(C(=O)NC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 DOVUJQMOXPYQMQ-UHFFFAOYSA-N 0.000 claims 1
- KKYCOCFTHSEGSX-UHFFFAOYSA-N 1-[4-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]-2,3-dihydro-1h-inden-1-yl]-2-oxo-n-(4-phenylphenyl)pyridine-3-carboxamide Chemical compound C1CC=2C(OCCOCCOCCO)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=CC=C1 KKYCOCFTHSEGSX-UHFFFAOYSA-N 0.000 claims 1
- XUWPENNWWFSKNQ-UHFFFAOYSA-N 1-[4-[4-[2-[2-[2-(2-aminoethoxy)ethoxy]ethoxy]acetyl]piperazin-1-yl]-2,3-dihydro-1h-inden-1-yl]-n-(4-chlorophenyl)-2-oxopyridine-3-carboxamide Chemical compound C1CN(C(=O)COCCOCCOCCN)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CC(Cl)=CC=2)=CC=C1 XUWPENNWWFSKNQ-UHFFFAOYSA-N 0.000 claims 1
- TYNSEQWDCJNOFZ-UHFFFAOYSA-N 2-oxo-1-(4-phenyl-2,3-dihydro-1h-inden-1-yl)-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)C=3C=CC=CC=3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 TYNSEQWDCJNOFZ-UHFFFAOYSA-N 0.000 claims 1
- DBTUKGQQHXXZRH-UHFFFAOYSA-N 2-oxo-1-(4-piperazin-1-yl-2,3-dihydro-1h-inden-1-yl)-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)N3CCNCC3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 DBTUKGQQHXXZRH-UHFFFAOYSA-N 0.000 claims 1
- UPUNKRHTHQKKLY-UHFFFAOYSA-N 2-oxo-1-(4-propan-2-yloxy-2,3-dihydro-1h-inden-1-yl)-n-pyridin-4-ylpyridine-3-carboxamide Chemical compound C1CC=2C(OC(C)C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 UPUNKRHTHQKKLY-UHFFFAOYSA-N 0.000 claims 1
- MMPSZOGBQOYPSL-UHFFFAOYSA-N 2-oxo-n-pyridin-4-yl-1-(4-pyridin-3-yl-2,3-dihydro-1h-inden-1-yl)pyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)C=3C=NC=CC=3)CC2)C(=O)C=1C(=O)NC1=CC=NC=C1 MMPSZOGBQOYPSL-UHFFFAOYSA-N 0.000 claims 1
- UKVNNYDWFGPHLQ-UHFFFAOYSA-N 2-oxo-n-pyridin-4-yl-1-[4-(trifluoromethoxy)-2,3-dihydro-1h-inden-1-yl]pyridine-3-carboxamide Chemical compound C1CC=2C(OC(F)(F)F)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=NC=C1 UKVNNYDWFGPHLQ-UHFFFAOYSA-N 0.000 claims 1
- 206010009900 Colitis ulcerative Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 102000004264 Osteopontin Human genes 0.000 claims 1
- 108010081689 Osteopontin Proteins 0.000 claims 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 1
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 1
- 108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 claims 1
- 102100023543 Vascular cell adhesion protein 1 Human genes 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000012875 competitive assay Methods 0.000 claims 1
- 125000001316 cycloalkyl alkyl group Chemical group 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- KZIJJWKMBXYYTH-UHFFFAOYSA-N n-(3,4-difluorophenyl)-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(F)C(F)=C1 KZIJJWKMBXYYTH-UHFFFAOYSA-N 0.000 claims 1
- QSSHCHGMGGSIMU-UHFFFAOYSA-N n-(3,4-difluorophenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=C(F)C(F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 QSSHCHGMGGSIMU-UHFFFAOYSA-N 0.000 claims 1
- BMXFFTVPJAGAJF-UHFFFAOYSA-N n-(4,4-difluorocyclohexyl)-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1CCC(F)(F)CC1 BMXFFTVPJAGAJF-UHFFFAOYSA-N 0.000 claims 1
- YVGJXLHSJWYZIG-UHFFFAOYSA-N n-(4,4-difluorocyclohexyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC(F)(F)CCC1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 YVGJXLHSJWYZIG-UHFFFAOYSA-N 0.000 claims 1
- JTWIFVZROQHSFK-UHFFFAOYSA-N n-(4-bromophenyl)-1-(4-hydroxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(O)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Br)C=C1 JTWIFVZROQHSFK-UHFFFAOYSA-N 0.000 claims 1
- TUYLNPCHEGGGNQ-UHFFFAOYSA-N n-(4-bromophenyl)-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Br)C=C1 TUYLNPCHEGGGNQ-UHFFFAOYSA-N 0.000 claims 1
- FYXQPROIXXPHNK-UHFFFAOYSA-N n-(4-bromophenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Br)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 FYXQPROIXXPHNK-UHFFFAOYSA-N 0.000 claims 1
- IWSACEXKDIDSSW-UHFFFAOYSA-N n-(4-bromophenyl)-1-[4-(2-hydroxyethoxy)-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OCCO)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Br)C=C1 IWSACEXKDIDSSW-UHFFFAOYSA-N 0.000 claims 1
- CMAUXRHGSUFQHT-UHFFFAOYSA-N n-(4-bromophenyl)-1-[4-[2-[2-(2-hydroxyethoxy)ethoxy]ethoxy]-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OCCOCCOCCO)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Br)C=C1 CMAUXRHGSUFQHT-UHFFFAOYSA-N 0.000 claims 1
- PQXYVIURQPDYJN-UHFFFAOYSA-N n-(4-bromophenyl)-2-oxo-1-(4-piperazin-1-yl-2,3-dihydro-1h-inden-1-yl)pyridine-3-carboxamide Chemical compound C1=CC(Br)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCNCC3)=C2CC1 PQXYVIURQPDYJN-UHFFFAOYSA-N 0.000 claims 1
- GPYKSKBWPPOLEF-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C2=CC=CC=C2CC1 GPYKSKBWPPOLEF-UHFFFAOYSA-N 0.000 claims 1
- DOQNWQCYXSGTBE-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(3-methyl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C12=CC=CC=C2C(C)CC1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 DOQNWQCYXSGTBE-UHFFFAOYSA-N 0.000 claims 1
- YBEKNASOCUYZEO-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(4-cyclopropyl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2C3CC3)=C2CC1 YBEKNASOCUYZEO-UHFFFAOYSA-N 0.000 claims 1
- JUENETMURFSLCN-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 JUENETMURFSLCN-UHFFFAOYSA-N 0.000 claims 1
- UEVOFCXPYYCENN-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(4-methylsulfonyl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(S(=O)(=O)C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 UEVOFCXPYYCENN-UHFFFAOYSA-N 0.000 claims 1
- XKAHONKNAQNURA-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 XKAHONKNAQNURA-UHFFFAOYSA-N 0.000 claims 1
- IVDGZINPJBFSCF-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(5-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC2=CC(OC)=CC=C2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 IVDGZINPJBFSCF-UHFFFAOYSA-N 0.000 claims 1
- QTNSLFWDPHXFNV-UHFFFAOYSA-N n-(4-chlorophenyl)-1-(6-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C12=CC(OC)=CC=C2CCC1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 QTNSLFWDPHXFNV-UHFFFAOYSA-N 0.000 claims 1
- GPYKSKBWPPOLEF-LJQANCHMSA-N n-(4-chlorophenyl)-1-[(1r)-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1[C@H]1C2=CC=CC=C2CC1 GPYKSKBWPPOLEF-LJQANCHMSA-N 0.000 claims 1
- AGDIKYWRWLPPGL-RBUKOAKNSA-N n-(4-chlorophenyl)-1-[(1r,2s)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound O=C1N([C@@H]2C3=CC=CC=C3C[C@@H]2O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 AGDIKYWRWLPPGL-RBUKOAKNSA-N 0.000 claims 1
- GPYKSKBWPPOLEF-IBGZPJMESA-N n-(4-chlorophenyl)-1-[(1s)-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1[C@@H]1C2=CC=CC=C2CC1 GPYKSKBWPPOLEF-IBGZPJMESA-N 0.000 claims 1
- AGDIKYWRWLPPGL-MOPGFXCFSA-N n-(4-chlorophenyl)-1-[(1s,2r)-2-hydroxy-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound O=C1N([C@H]2C3=CC=CC=C3C[C@H]2O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 AGDIKYWRWLPPGL-MOPGFXCFSA-N 0.000 claims 1
- WCFFKNLJNKFSKV-UHFFFAOYSA-N n-(4-chlorophenyl)-1-[4-(4-methylsulfonylpiperazin-1-yl)-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1CN(S(=O)(=O)C)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CC(Cl)=CC=2)=CC=C1 WCFFKNLJNKFSKV-UHFFFAOYSA-N 0.000 claims 1
- MCVUESRCIUEVBT-UHFFFAOYSA-N n-(4-chlorophenyl)-1-[4-[4-(2-hydroxyethyl)piperazin-1-yl]-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1CN(CCO)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CC(Cl)=CC=2)=CC=C1 MCVUESRCIUEVBT-UHFFFAOYSA-N 0.000 claims 1
- XLMPERUYAURCDW-UHFFFAOYSA-N n-(4-chlorophenyl)-1-[4-[4-[2-[2-(2-hydroxyethoxy)ethoxy]ethyl]piperazin-1-yl]-2,3-dihydro-1h-inden-1-yl]-2-oxopyridine-3-carboxamide Chemical compound C1CN(CCOCCOCCO)CCN1C1=CC=CC2=C1CCC2N1C(=O)C(C(=O)NC=2C=CC(Cl)=CC=2)=CC=C1 XLMPERUYAURCDW-UHFFFAOYSA-N 0.000 claims 1
- KFZGMLHEJPJGPF-UHFFFAOYSA-N n-(4-chlorophenyl)-2-oxo-1-(4-piperazin-1-yl-2,3-dihydro-1h-inden-1-yl)pyridine-3-carboxamide Chemical compound C1=CC(Cl)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCNCC3)=C2CC1 KFZGMLHEJPJGPF-UHFFFAOYSA-N 0.000 claims 1
- VTHSVMKBVHTVQK-UHFFFAOYSA-N n-(4-chlorophenyl)-2-oxo-1-(4-propan-2-yloxy-2,3-dihydro-1h-inden-1-yl)pyridine-3-carboxamide Chemical compound C1CC=2C(OC(C)C)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 VTHSVMKBVHTVQK-UHFFFAOYSA-N 0.000 claims 1
- KDNCSAYNQPIUNG-UHFFFAOYSA-N n-(4-chlorophenyl)-2-oxo-1-[4-(trifluoromethoxy)-2,3-dihydro-1h-inden-1-yl]pyridine-3-carboxamide Chemical compound C1CC=2C(OC(F)(F)F)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(Cl)C=C1 KDNCSAYNQPIUNG-UHFFFAOYSA-N 0.000 claims 1
- QHFVQLSKQGAFLS-UHFFFAOYSA-N n-(4-cyanophenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)N3CCOCC3)CC2)C(=O)C=1C(=O)NC1=CC=C(C#N)C=C1 QHFVQLSKQGAFLS-UHFFFAOYSA-N 0.000 claims 1
- KCHPRFYSPUDDAB-UHFFFAOYSA-N n-(4-fluorophenyl)-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(F)C=C1 KCHPRFYSPUDDAB-UHFFFAOYSA-N 0.000 claims 1
- WYHFRIHVHLTYIR-UHFFFAOYSA-N n-(4-fluorophenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 WYHFRIHVHLTYIR-UHFFFAOYSA-N 0.000 claims 1
- FCYVRKSBZJTFJV-UHFFFAOYSA-N n-(4-fluorophenyl)-2-oxo-1-(4-piperazin-1-yl-2,3-dihydro-1h-inden-1-yl)pyridine-3-carboxamide Chemical compound C1=CC(F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCNCC3)=C2CC1 FCYVRKSBZJTFJV-UHFFFAOYSA-N 0.000 claims 1
- IIWSBUKWODLEKS-UHFFFAOYSA-N n-(4-iodophenyl)-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1=CC=C(I)C=C1 IIWSBUKWODLEKS-UHFFFAOYSA-N 0.000 claims 1
- DGTPBRNONUUWKM-UHFFFAOYSA-N n-(4-iodophenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(I)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 DGTPBRNONUUWKM-UHFFFAOYSA-N 0.000 claims 1
- XWBYOAOSNXJUJL-UHFFFAOYSA-N n-(4-methoxyphenyl)-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 XWBYOAOSNXJUJL-UHFFFAOYSA-N 0.000 claims 1
- ZLZGMQCUAMVEQR-UHFFFAOYSA-N n-[4-(3-ethoxyphenyl)phenyl]-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound CCOC1=CC=CC(C=2C=CC(NC(=O)C=3C(N(C4C5=C(C(=CC=C5)OC)CC4)C=CC=3)=O)=CC=2)=C1 ZLZGMQCUAMVEQR-UHFFFAOYSA-N 0.000 claims 1
- CAGPATUTEHOHOQ-UHFFFAOYSA-N n-[4-(3-hydroxyphenyl)phenyl]-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=CC(O)=C1 CAGPATUTEHOHOQ-UHFFFAOYSA-N 0.000 claims 1
- ZLTXJHIHOZGEHA-UHFFFAOYSA-N n-[4-(4-aminophenyl)phenyl]-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=C(N)C=C1 ZLTXJHIHOZGEHA-UHFFFAOYSA-N 0.000 claims 1
- CGWJEBBGFKMTHD-UHFFFAOYSA-N n-[4-(4-hydroxyphenyl)phenyl]-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC(C=C1)=CC=C1C1=CC=C(O)C=C1 CGWJEBBGFKMTHD-UHFFFAOYSA-N 0.000 claims 1
- LTLDWOWHFWDHOP-UHFFFAOYSA-N n-[4-(4-methoxyanilino)phenyl]-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(OC)=CC=C1NC(C=C1)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 LTLDWOWHFWDHOP-UHFFFAOYSA-N 0.000 claims 1
- RJTXLRFGKBANFQ-UHFFFAOYSA-N n-[4-(difluoromethoxy)phenyl]-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(OC(F)F)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 RJTXLRFGKBANFQ-UHFFFAOYSA-N 0.000 claims 1
- ZRJSSENUSSKGMT-UHFFFAOYSA-N n-[4-(dimethylamino)phenyl]-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1=CC(N(C)C)=CC=C1NC(=O)C(C1=O)=CC=CN1C1C(C=CC=C2N3CCOCC3)=C2CC1 ZRJSSENUSSKGMT-UHFFFAOYSA-N 0.000 claims 1
- XNZJEIZZDNELFJ-UHFFFAOYSA-N n-cyclohexyl-1-(4-methoxy-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C1CC=2C(OC)=CC=CC=2C1N(C1=O)C=CC=C1C(=O)NC1CCCCC1 XNZJEIZZDNELFJ-UHFFFAOYSA-N 0.000 claims 1
- RWBINACOBDDDGF-UHFFFAOYSA-N n-cyclohexyl-1-(4-morpholin-4-yl-2,3-dihydro-1h-inden-1-yl)-2-oxopyridine-3-carboxamide Chemical compound C=1C=CN(C2C3=C(C(=CC=C3)N3CCOCC3)CC2)C(=O)C=1C(=O)NC1CCCCC1 RWBINACOBDDDGF-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 150000003557 thiazoles Chemical class 0.000 claims 1
- 150000003577 thiophenes Chemical class 0.000 claims 1
- 0 *C(C(*)=C1C(N(*)*)=O)=C(*)N(C(C2)CC3C2****3)C1=O Chemical compound *C(C(*)=C1C(N(*)*)=O)=C(*)N(C(C2)CC3C2****3)C1=O 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17287609P | 2009-04-27 | 2009-04-27 | |
| US61/172,876 | 2009-04-27 | ||
| PCT/US2010/032632 WO2010126914A1 (en) | 2009-04-27 | 2010-04-27 | Pyridinone antagonists of alpha-4 integrins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012525336A JP2012525336A (ja) | 2012-10-22 |
| JP2012525336A5 true JP2012525336A5 (https=) | 2013-06-13 |
Family
ID=42235905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012507475A Pending JP2012525336A (ja) | 2009-04-27 | 2010-04-27 | α−４インテグリンのピリジノンアンタゴニスト |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8367836B2 (https=) |
| EP (1) | EP2424841A1 (https=) |
| JP (1) | JP2012525336A (https=) |
| CN (1) | CN102459179A (https=) |
| AU (1) | AU2010241742A1 (https=) |
| BR (1) | BRPI1015259A2 (https=) |
| CA (1) | CA2760151A1 (https=) |
| IL (1) | IL215956A0 (https=) |
| MX (1) | MX2011011326A (https=) |
| SG (2) | SG10201401836RA (https=) |
| WO (1) | WO2010126914A1 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102099036B (zh) | 2008-06-03 | 2015-05-27 | 英特芒尼公司 | 用于治疗炎性疾患和纤维化疾患的化合物和方法 |
| PE20130774A1 (es) * | 2010-07-29 | 2013-06-26 | Rigel Pharmaceuticals Inc | Compuestos heterociclicos activadores de ampk y metodos para emplearlos |
| KR101317656B1 (ko) * | 2011-06-30 | 2013-10-15 | 연세대학교 산학협력단 | 복제효소 인산화를 조절하는 신규 ｃ형 간염 예방 또는 치료용 조성물 |
| EP2562174A1 (de) * | 2011-08-24 | 2013-02-27 | Bayer Cropscience AG | Herbizid wirksame 6-Oxo-1,6-dihydropyrimidin-5-carboxamide und 2-Oxo-1,2-dihydropyridin-3-carboxamide |
| DK2810937T3 (en) * | 2012-01-31 | 2017-03-13 | Daiichi Sankyo Co Ltd | PYRIDONE DERIVATIVES |
| BR112014027644A2 (pt) * | 2012-05-09 | 2017-06-27 | Bayer Cropscience Ag | 5-halogenopirazol-indanil-carboxamidas |
| AR092742A1 (es) | 2012-10-02 | 2015-04-29 | Intermune Inc | Piridinonas antifibroticas |
| MX382781B (es) | 2014-04-02 | 2025-03-13 | Intermune Inc | Piridinonas anti-fibroticas. |
| TWI723572B (zh) * | 2014-07-07 | 2021-04-01 | 日商第一三共股份有限公司 | 具有四氫吡喃基甲基之吡啶酮衍生物及其用途 |
| US9840513B2 (en) * | 2015-07-16 | 2017-12-12 | Abbvie S.Á.R.L. | Substituted tricyclics and method of use |
| WO2019200114A1 (en) * | 2018-04-12 | 2019-10-17 | Arbutus Biopharma Corporation | Methods for preparing substituted dihydroindene-4-carboxamide compounds |
| JP7189368B2 (ja) | 2018-10-30 | 2022-12-13 | ギリアード サイエンシーズ， インコーポレイテッド | アルファ４ベータ７インテグリンの阻害のための化合物 |
| FI3873884T3 (fi) | 2018-10-30 | 2025-02-24 | Gilead Sciences Inc | 3-(kinolin-8-yyli)-1,4-dihydropyrido[3,4-d]pyrimidiini-2,4-dionijohdannaisia alfa-4-beta-7-integriinin estäjinä tulehdussairauksien hoidossa |
| ES3013256T3 (en) | 2018-10-30 | 2025-04-11 | Gilead Sciences Inc | Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases |
| EP3873605B1 (en) | 2018-10-30 | 2024-10-23 | Gilead Sciences, Inc. | Compounds for inhibition of alpha4beta7 integrin |
| KR20210143783A (ko) * | 2019-02-28 | 2021-11-29 | 케자르 라이프 사이언스 | 단백질 분비 저해제로서 티아졸 유도체 |
| US20220289679A1 (en) * | 2019-07-29 | 2022-09-15 | Takeda Pharmaceutical Company Limited | Heterocyclic compound |
| WO2021030438A1 (en) | 2019-08-14 | 2021-02-18 | Gilead Sciences, Inc. | Compounds for inhibition of alpha 4 beta 7 integrin |
| WO2022169248A1 (ko) * | 2021-02-02 | 2022-08-11 | 주식회사 엘지화학 | 단백질 키나아제 억제제로서의 신규한 화합물 |
| TW202511256A (zh) * | 2023-05-25 | 2025-03-16 | 大陸商北京雙鶴潤創科技有限公司 | 肌成束蛋白抑制劑 |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2525656A1 (de) | 1974-06-19 | 1976-01-15 | Sandoz Ag | Verfahren zur herstellung neuer heterocyclischer verbindungen |
| US4041156A (en) | 1974-11-08 | 1977-08-09 | Mitsubishi Chemical Industries Limited | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4073914A (en) | 1974-11-08 | 1978-02-14 | Mitsubishi Chemical Industries Limited | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4055636A (en) | 1974-11-08 | 1977-10-25 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4096255A (en) | 1974-11-08 | 1978-06-20 | Mitsubishi Chemical Industries Limited | N2 -naphthalenesulfonyl-L-argininamides, and pharmaceutical salts, compositions and methods |
| US4104392A (en) | 1974-11-08 | 1978-08-01 | Mitsubishi Chemical Industries Ltd. | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, and antithrombotic compositions and methods employing them |
| US4046876A (en) | 1974-11-08 | 1977-09-06 | Mitsubishi Chemical Industries Limited | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4070457A (en) | 1974-11-08 | 1978-01-24 | Mitsubishi Chemical Industries Ltd. | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4018915A (en) | 1976-01-05 | 1977-04-19 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4055651A (en) | 1974-11-08 | 1977-10-25 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| JPS5727454B2 (https=) | 1975-02-21 | 1982-06-10 | ||
| US4036955A (en) | 1976-07-22 | 1977-07-19 | Mitsubishi Chemical Industries Ltd. | N2 -naphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| US4018913A (en) | 1976-01-14 | 1977-04-19 | Mitsubishi Chemical Industries Ltd. | N2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
| CA1102316A (en) | 1975-12-09 | 1981-06-02 | Shosuke Okamoto | N su2 xx-arylsulfonyl-l-argininamides and the pharmaceutically acceptable salts thereof |
| DE2742173A1 (de) | 1977-09-20 | 1979-03-29 | Bayer Ag | Phenoxy-pyridinyl(pyrimidinyl)-alkanole, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| IT1211096B (it) | 1981-08-20 | 1989-09-29 | Lpb Ist Farm | Pirimidine e s.triazinici adattivita' ipolipidemizzante. |
| US4672065A (en) | 1982-11-19 | 1987-06-09 | Chevron Research Company | N-substituted phenoxyacetamide fungicides |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| CA1218655A (en) | 1983-01-28 | 1987-03-03 | Kathleen Biziere | Process for the preparation of pyridazine derivatives having a psychotropic action |
| JPS59212480A (ja) | 1983-05-17 | 1984-12-01 | Nippon Soda Co Ltd | ピリダジン誘導体及び除草剤 |
| DE3322720A1 (de) | 1983-06-24 | 1985-01-03 | Chemische Werke Hüls AG, 4370 Marl | Verwendung von in 2-stellung mit (substituierten) aminogruppen substituierten 4-dl-alkylester-(alpha)-alaninyl-6-chlor-s-triazinen als herbizide, insbesondere gegen flughafer |
| US4505910A (en) | 1983-06-30 | 1985-03-19 | American Home Products Corporation | Amino-pyrimidine derivatives, compositions and use |
| NZ210669A (en) | 1983-12-27 | 1988-05-30 | Syntex Inc | Benzoxazin-4-one derivatives and pharmaceutical compositions |
| PH22520A (en) | 1984-11-12 | 1988-10-17 | Yamanouchi Pharma Co Ltd | Heterocyclic compounds having 4-lover alkyl-3-hydroxy-2-lower alkyl phenoxy-lower alkylene-y-group, and process of producing them |
| US4959364A (en) | 1985-02-04 | 1990-09-25 | G. D. Searle & Co. | Method of treating inflammation, allergy, asthma and proliferative skin disease using heterocyclic amides |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0784424B2 (ja) | 1987-04-15 | 1995-09-13 | 味の素株式会社 | チロシン誘導体及びその用途 |
| EP0330506A3 (en) | 1988-02-26 | 1990-06-20 | Dana Farber Cancer Institute | Vla proteins |
| US5011472A (en) | 1988-09-06 | 1991-04-30 | Brown University Research Foundation | Implantable delivery system for biological factors |
| DE3904931A1 (de) | 1989-02-17 | 1990-08-23 | Bayer Ag | Pyridyl-substituierte acrylsaeureester |
| US5030644A (en) | 1989-07-31 | 1991-07-09 | Merck & Co., Inc. | Imidazole compounds and their use as transglutaminase inhibitors |
| US5260210A (en) | 1989-09-27 | 1993-11-09 | Rubin Lee L | Blood-brain barrier model |
| US4992439A (en) | 1990-02-13 | 1991-02-12 | Bristol-Myers Squibb Company | Pyridazine carboxylic acids and esters |
| FR2679903B1 (fr) | 1991-08-02 | 1993-12-03 | Elf Sanofi | Derives de la n-sulfonyl indoline portant une fonction amidique, leur preparation, les compositions pharmaceutiques en contenant. |
| NZ239846A (en) | 1990-09-27 | 1994-11-25 | Merck & Co Inc | Sulphonamide derivatives and pharmaceutical compositions thereof |
| DE4108029A1 (de) | 1991-03-13 | 1992-09-17 | Bayer Ag | Triazinyl-substituierte acrylsaeureester |
| AU1354292A (en) | 1991-03-18 | 1992-10-21 | Pentapharm Ag | Parasubstituted phenylalanine derivates |
| IT1247509B (it) | 1991-04-19 | 1994-12-17 | Univ Cagliari | Composti di sintesi atti all'impiego nella terapia delle infezioni da rhinovirus |
| US5296486A (en) | 1991-09-24 | 1994-03-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Leukotriene biosynthesis inhibitors |
| WO1993012809A1 (en) | 1991-12-24 | 1993-07-08 | Fred Hutchinson Cancer Research Center | Competitive inhibition of high-avidity alpha4-beta1 receptor using tripeptide ldv |
| JPH07504654A (ja) | 1992-03-11 | 1995-05-25 | ナルヘックス リミテッド | オキソ及びヒドロキシ置換炭化水素のアミン誘導体 |
| GB9307555D0 (en) * | 1992-04-16 | 1993-06-02 | Zeneca Ltd | Heterocyclic compounds |
| US5518730A (en) | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
| DE4227748A1 (de) | 1992-08-21 | 1994-02-24 | Bayer Ag | Pyridyloxy-acrylsäureester |
| JP2848232B2 (ja) | 1993-02-19 | 1999-01-20 | 武田薬品工業株式会社 | アルデヒド誘導体 |
| US5770573A (en) | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
| TW530047B (en) | 1994-06-08 | 2003-05-01 | Pfizer | Corticotropin releasing factor antagonists |
| US5510332A (en) | 1994-07-07 | 1996-04-23 | Texas Biotechnology Corporation | Process to inhibit binding of the integrin α4 62 1 to VCAM-1 or fibronectin and linear peptides therefor |
| AU2964295A (en) | 1994-07-11 | 1996-02-09 | Athena Neurosciences, Inc. | Inhibitors of leukocyte adhesion |
| US6306840B1 (en) | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
| IL117659A (en) | 1995-04-13 | 2000-12-06 | Dainippon Pharmaceutical Co | Substituted 2-phenyl pyrimidino amino acetamide derivative process for preparing the same and a pharmaceutical composition containing same |
| PT765879E (pt) | 1995-09-29 | 2001-05-31 | Sankyo Co | Derivados 13-substituidos de milbemicina-5-oxima sua preparacao e utilizacao contra insectos e outras pragas |
| DE19536891A1 (de) | 1995-10-04 | 1997-04-10 | Basf Ag | Neue Aminosäurederivate, ihre Herstellung und Verwendung |
| DE19548709A1 (de) | 1995-12-23 | 1997-07-03 | Merck Patent Gmbh | Tyrosinderivate |
| DK0910575T3 (da) | 1996-06-21 | 2003-02-03 | Takeda Chemical Industries Ltd | Fremgangsmåde til fremstilling af peptider |
| EP0907637A1 (de) | 1996-06-28 | 1999-04-14 | MERCK PATENT GmbH | Phenylalanin-derivate als integrin-inhibitoren |
| DE19654483A1 (de) | 1996-06-28 | 1998-01-02 | Merck Patent Gmbh | Phenylalanin-Derivate |
| DE19629817A1 (de) | 1996-07-24 | 1998-01-29 | Hoechst Ag | Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten |
| DE19647317A1 (de) | 1996-11-15 | 1998-05-20 | Hoechst Schering Agrevo Gmbh | Substituierte Stickstoff-Heterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel |
| DE19713000A1 (de) | 1997-03-27 | 1998-10-01 | Merck Patent Gmbh | Adhäsionsrezeptor-Antagonisten |
| HK1043794A1 (zh) | 1999-01-22 | 2002-09-27 | 依兰制药公司 | 抑制vla-4介导的白细胞粘附的稠合环杂芳基和杂环化合物 |
| ATE455106T1 (de) | 1999-01-22 | 2010-01-15 | Elan Pharm Inc | Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen |
| US6436904B1 (en) | 1999-01-25 | 2002-08-20 | Elan Pharmaceuticals, Inc. | Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| ATE383153T1 (de) * | 1999-05-07 | 2008-01-15 | Encysive Pharmaceuticals Inc | Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen |
| AU782616B2 (en) * | 1999-05-07 | 2005-08-11 | Encysive Pharmaceuticals Inc. | Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| US6544994B2 (en) | 2000-06-07 | 2003-04-08 | Eprov Ag | Pharmaceutical preparation for treating or preventing cardiovascular or neurological disorders by modulating of the activity of nitric oxide synthase |
| WO2002008206A1 (en) | 2000-07-21 | 2002-01-31 | Elan Pharmaceuticals, Inc. | 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors |
| US6794506B2 (en) | 2000-07-21 | 2004-09-21 | Elan Pharmaceuticals, Inc. | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| KR100828982B1 (ko) * | 2000-12-28 | 2008-05-14 | 시오노기세이야쿠가부시키가이샤 | 칸나비노이드 2형 수용체 친화 작용을 갖는 피리돈 유도체 |
| SI21096B (sl) * | 2001-10-09 | 2012-05-31 | Encysive Pharmaceuticals Inc | Derivati karboksilne kisline ki inhibirajo vezavo integrinov na njihove receptorje |
| TWI281470B (en) | 2002-05-24 | 2007-05-21 | Elan Pharm Inc | Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| TW200307671A (en) | 2002-05-24 | 2003-12-16 | Elan Pharm Inc | Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins |
| WO2004046122A2 (en) * | 2002-11-16 | 2004-06-03 | Oxford Glycosciences (Uk) Ltd | Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors |
| SE0302486D0 (sv) * | 2003-09-18 | 2003-09-18 | Astrazeneca Ab | Novel compounds |
| US20050176755A1 (en) * | 2003-10-31 | 2005-08-11 | Dyatkin Alexey B. | Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists |
| ATE371649T1 (de) * | 2004-02-10 | 2007-09-15 | Janssen Pharmaceutica Nv | Pyridazinonharnstoffe als antagonisten von a4- integrinen |
| US7794700B2 (en) | 2004-07-08 | 2010-09-14 | Elan Pharmaceuticals Inc. | Multimeric VLA-4 antagonists comprising polymer moieties |
| TWI360539B (en) * | 2004-10-28 | 2012-03-21 | Shionogi & Co | 3-carbamoyl-2-pyridone derivatives |
| US20060116713A1 (en) * | 2004-11-26 | 2006-06-01 | Ivan Sepetka | Aneurysm treatment devices and methods |
| JO2787B1 (en) * | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| WO2007008541A2 (en) * | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
| CA2624524C (en) | 2005-09-29 | 2014-07-08 | Elan Pharmaceuticals, Inc. | Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4 |
| BRPI0616687A2 (pt) | 2005-09-29 | 2011-06-28 | Elan Pharm Inc | compostos de pirimidinil amida que inibem a adesão leucocitária mediada por vla-4 |
| JP2009526761A (ja) * | 2006-01-30 | 2009-07-23 | アレイ バイオファーマ、インコーポレイテッド | ヘテロ二環式チオフェン化合物および使用の方法 |
| CA2643838A1 (en) | 2006-02-27 | 2007-09-07 | Elan Pharmaceuticals, Inc. | Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| EP2038272B8 (en) * | 2006-06-30 | 2013-10-23 | Sunesis Pharmaceuticals, Inc. | Pyridinonyl pdk1 inhibitors |
| WO2008084671A1 (ja) * | 2006-12-27 | 2008-07-17 | Shionogi & Co., Ltd. | １－置換－２－ピリドン－３－カルボン酸誘導体の製造方法 |
| US8518975B2 (en) * | 2007-09-06 | 2013-08-27 | Merck Sharp + Dohme Corp. | Gamma secretase modulators |
-
2010
- 2010-04-27 WO PCT/US2010/032632 patent/WO2010126914A1/en not_active Ceased
- 2010-04-27 SG SG10201401836RA patent/SG10201401836RA/en unknown
- 2010-04-27 MX MX2011011326A patent/MX2011011326A/es active IP Right Grant
- 2010-04-27 BR BRPI1015259A patent/BRPI1015259A2/pt not_active IP Right Cessation
- 2010-04-27 JP JP2012507475A patent/JP2012525336A/ja active Pending
- 2010-04-27 CA CA2760151A patent/CA2760151A1/en not_active Abandoned
- 2010-04-27 AU AU2010241742A patent/AU2010241742A1/en not_active Abandoned
- 2010-04-27 EP EP10719684A patent/EP2424841A1/en not_active Withdrawn
- 2010-04-27 SG SG2011078409A patent/SG175355A1/en unknown
- 2010-04-27 US US12/768,680 patent/US8367836B2/en not_active Expired - Fee Related
- 2010-04-27 CN CN2010800273757A patent/CN102459179A/zh active Pending
-
2011
- 2011-10-26 IL IL215956A patent/IL215956A0/en unknown
-
2012
- 2012-12-28 US US13/730,522 patent/US20130252957A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012525336A5 (https=) | ||
| JP6440321B2 (ja) | スルホンアミド誘導体またはその薬学的に許容される酸付加塩 | |
| JP2023514872A5 (https=) | ||
| TWI567067B (zh) | ＴｒＫ抑制化合物 | |
| US8003642B2 (en) | Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient | |
| JP2018522823A5 (https=) | ||
| JP2015517981A5 (https=) | ||
| CA2529686C (en) | 2-acylaminothiazole derivative or salt thereof | |
| JP5059275B2 (ja) | 新規３置換尿素誘導体およびその医薬としての用途 | |
| JP2004504301A5 (https=) | ||
| ES2533954T3 (es) | Derivados de resorcinol como inhibidores de HSP90 | |
| RU2013143028A (ru) | Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ | |
| RU2013130925A (ru) | Оксимовые соединения в качестве средств для повышения уровня холестерина высокой плотности | |
| RU2010101633A (ru) | Новое сульфонамидное производное малоновой кислоты и его фармацевтическое применение | |
| RU2005108999A (ru) | Азотсодержащие ароматические производные | |
| JP2010526096A5 (ja) | キナーゼ阻害剤として有用なチアゾールおよびピラゾール | |
| TW200815422A (en) | Heteroaryl derivatives as cytokine inhibitors | |
| RU2017145650A (ru) | Ингибиторы тирозинкиназы брутона | |
| JP2014511869A5 (https=) | ||
| TWI226240B (en) | Piperazine compound | |
| RS50755B (sr) | Supstituisani aril i heteroaril derivati kao modulatori metabolizma i profilakse i lečenje poremećaja proisteklih iz toga | |
| TW200914440A (en) | Vinyl-aryl derivatives for inflammation and immune-related uses | |
| TWI317359B (en) | N-phenyl-arylsulfonamide compound and the pharmaceuticals containing the same as active ingredient | |
| RU2018131766A (ru) | 6-гетероциклил-4-морфолин-4-илпиридин-2-оны, пригодные для лечения рака и диабета | |
| RU2012134093A (ru) | 4-фенокси-никотинамиды или 4-фенокси-пиримидин-5-карбоксамиды |